JP2022521266A5 - - Google Patents
Info
- Publication number
- JP2022521266A5 JP2022521266A5 JP2021549163A JP2021549163A JP2022521266A5 JP 2022521266 A5 JP2022521266 A5 JP 2022521266A5 JP 2021549163 A JP2021549163 A JP 2021549163A JP 2021549163 A JP2021549163 A JP 2021549163A JP 2022521266 A5 JP2022521266 A5 JP 2022521266A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- iapp peptide
- iapp
- nos
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024091172A JP7825238B2 (ja) | 2019-02-22 | 2024-06-05 | アミロイドペプチドバリアント |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809167P | 2019-02-22 | 2019-02-22 | |
| US62/809,167 | 2019-02-22 | ||
| PCT/US2020/019557 WO2020172686A1 (en) | 2019-02-22 | 2020-02-24 | Amyloid peptide variants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024091172A Division JP7825238B2 (ja) | 2019-02-22 | 2024-06-05 | アミロイドペプチドバリアント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022521266A JP2022521266A (ja) | 2022-04-06 |
| JP2022521266A5 true JP2022521266A5 (https=) | 2022-11-14 |
| JP7505713B2 JP7505713B2 (ja) | 2024-06-25 |
Family
ID=72145021
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549163A Active JP7505713B2 (ja) | 2019-02-22 | 2020-02-24 | アミロイドペプチドバリアント |
| JP2024091172A Active JP7825238B2 (ja) | 2019-02-22 | 2024-06-05 | アミロイドペプチドバリアント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024091172A Active JP7825238B2 (ja) | 2019-02-22 | 2024-06-05 | アミロイドペプチドバリアント |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12522635B2 (https=) |
| EP (1) | EP3927725A4 (https=) |
| JP (2) | JP7505713B2 (https=) |
| CN (2) | CN118955675A (https=) |
| IL (1) | IL285699A (https=) |
| WO (1) | WO2020172686A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021233942A1 (en) * | 2020-05-19 | 2021-11-25 | Empa Eidgenössische Materialprüfungs- Und Forschungsanstalt | Detection and imaging of amyloid aggregates in blood |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE454299B (sv) * | 1986-10-08 | 1988-04-18 | Westermark P | Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden |
| HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| US5814600A (en) * | 1991-05-24 | 1998-09-29 | Amylin Pharmaceuticals Inc. | Method and composition for treatment of insulin requiring mammals |
| US7060670B1 (en) * | 1999-05-05 | 2006-06-13 | Neurochem (International) Limited | Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| ATE514707T1 (de) * | 2002-04-19 | 2011-07-15 | Univ Toronto | Immunologisches verfahren und zusammensetzungen für die behandlung der krankheit von alzheimer |
| JP2007527365A (ja) * | 2003-03-18 | 2007-09-27 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | アミリン凝集阻害剤およびその使用 |
| DE102004051014A1 (de) * | 2004-10-20 | 2006-04-27 | Rwth Aachen | Chemisch modifizierte Peptidanaloga |
| GB0501348D0 (en) * | 2005-01-24 | 2005-03-02 | Zyentia Ltd | Compositions and methods |
| AU2006341375B2 (en) * | 2006-03-31 | 2013-03-21 | Amylin Pharmaceuticals, Llc | Amylin and amylin agonists for treating psychiatric diseases and disorders |
| EP2036923A1 (en) * | 2007-09-11 | 2009-03-18 | Novo Nordisk A/S | Improved derivates of amylin |
| CA2812951A1 (en) | 2010-09-28 | 2012-04-19 | Amylin Pharmaceuticals, Llc | Engineered polypeptides having enhanced duration of action |
| US20130022620A1 (en) * | 2011-06-09 | 2013-01-24 | Ann Marie Schmidt | Assays and methods pertaining to pre-amyloid intermediates |
| JP6121992B2 (ja) * | 2011-06-10 | 2017-04-26 | ノヴォ ノルディスク アー／エス | ポリペプチド |
| US9475866B2 (en) * | 2012-09-12 | 2016-10-25 | Neurimmune Holding Ag | Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof |
| WO2015062803A1 (en) * | 2013-10-29 | 2015-05-07 | Kapurniotu Aphrodite | Modified segments of islet amyloid polypeptide |
| CN108070075A (zh) * | 2016-11-09 | 2018-05-25 | 可口可乐公司 | 生物基meg和聚酯纤维组合物以及制造它们的方法 |
| WO2018144671A1 (en) * | 2017-02-01 | 2018-08-09 | The Research Foundation For The State University Of New York | Mutant islet amyloid polypeptides with improved solubility and methods for using the same |
| WO2019241628A1 (en) * | 2018-06-15 | 2019-12-19 | Proclara Biosciences, Inc. | General amyloid interaction motif (gaim) |
-
2020
- 2020-02-24 JP JP2021549163A patent/JP7505713B2/ja active Active
- 2020-02-24 WO PCT/US2020/019557 patent/WO2020172686A1/en not_active Ceased
- 2020-02-24 EP EP20759401.1A patent/EP3927725A4/en active Pending
- 2020-02-24 CN CN202410844356.7A patent/CN118955675A/zh active Pending
- 2020-02-24 US US17/428,615 patent/US12522635B2/en active Active
- 2020-02-24 CN CN202080015845.1A patent/CN113614101B/zh active Active
-
2021
- 2021-08-18 IL IL285699A patent/IL285699A/en unknown
-
2024
- 2024-06-05 JP JP2024091172A patent/JP7825238B2/ja active Active
-
2025
- 2025-12-17 US US19/423,936 patent/US20260109744A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| AU2019334939B2 (en) | Combination therapy for the treatment of liver disease | |
| CN105228622B (zh) | 用于治疗多发性硬化的PPARγ激动剂 | |
| JP2009544585A5 (https=) | ||
| JP2022533968A5 (https=) | ||
| JP2019023202A (ja) | Ｌｓｄ１阻害剤を用いて多発性硬化症を処置する方法 | |
| JP2023500032A5 (https=) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2020536121A5 (https=) | ||
| JP2002511875A (ja) | 勃起機能障害治療用のヨヒンビンおよびアルギニン含有薬 | |
| JP2023531675A5 (https=) | ||
| JP2022521266A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| JP2004525940A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2020526525A5 (https=) | ||
| JP2022524576A5 (https=) | ||
| JP2023531930A5 (https=) | ||
| JP2021512086A5 (https=) | ||
| US3681497A (en) | Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide | |
| JP2021530568A5 (https=) | ||
| JP2022543598A5 (https=) | ||
| JP2021518392A5 (https=) | ||
| JP2004529158A5 (https=) |